Topics
July/August 2025 | Guest Editor's Page
A Hopeful Future for Patients with IRDs
Ben Shaberman, MA, MS
June 18, 2026
Ocular Therapeutix Aligns With FDA on Planned Axpaxli NDA Submission for Wet AMD
June 17, 2026
Bayer Completes Acquisition of Perfuse Therapeutics, Gains Full Rights to PER-001
June 15, 2026
Ethyreal Bio Presents Preclinical Data Supporting Clinical Advancement of ETHY-001 for Thyroid Eye Disease
BVI Opens Experience Hub in Spain to Expand Ophthalmic Surgical Education and Collaboration
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
